{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:26:02Z","timestamp":1792671962895,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020230","name":"Junta de Andaluc\u00eda Consejer\u00eda de Transformaci\u00f3n Econ\u00f3mica Industria Conocimiento y Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Junta de Andalucia Consejeria de Economia Innovacion y Ciencia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"EMBO","doi-asserted-by":"publisher","award":["10144"],"award-info":[{"award-number":["10144"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Gobierno de Espa\u00f1a Ministerio de Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica de la Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["PRDJA19001BLAY"],"award-info":[{"award-number":["PRDJA19001BLAY"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RTI2018.101309B-C22"],"award-info":[{"award-number":["RTI2018.101309B-C22"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CMC-CTS963"],"award-info":[{"award-number":["CMC-CTS963"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007320","name":"Albert Einstein Cancer Center","doi-asserted-by":"publisher","award":["INTRAIBS-2021-09"],"award-info":[{"award-number":["INTRAIBS-2021-09"]}],"id":[{"id":"10.13039\/100007320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI19\/01533"],"award-info":[{"award-number":["PI19\/01533"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP19\/00029"],"award-info":[{"award-number":["CP19\/00029"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116439","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T08:38:54Z","timestamp":1711010334000},"page":"116439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Unlocking the effective alliance of \u03b2-lapachone and hydroxytyrosol against triple-negative breast cancer cells"],"prefix":"10.1016","volume":"174","author":[{"given":"Jes\u00fas","family":"Calahorra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Blaya-C\u00e1novas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Castellini-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Aparicio-Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0430-838X","authenticated-orcid":false,"given":"Candela","family":"Cives-Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1186-6849","authenticated-orcid":false,"given":"Jose J.G.","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5565-5377","authenticated-orcid":false,"given":"Markel","family":"Rementeria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7541-6889","authenticated-orcid":false,"given":"Francisca E.","family":"Cara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"L\u00f3pez-Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gri\u00f1\u00e1n-Lis\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3097-3765","authenticated-orcid":false,"given":"Francesco","family":"Aulicino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imre","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4996-8261","authenticated-orcid":false,"given":"Juan A.","family":"Marchal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Delgado-Almenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8773-9489","authenticated-orcid":false,"given":"Sergio","family":"Granados-Principal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116439_bib1","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3390\/cancers14174280","article-title":"Challenges for triple negative breast cancer treatment: defeating heterogeneity and cancer stemness","volume":"14","author":"Mahmoud","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.116439_bib2","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/ijms23031665","article-title":"Molecular mechanisms, biomarkers and emerging therapies for chemotherapy resistant TNBC","volume":"23","author":"Ferrari","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116439_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112962","article-title":"A comprehensive review on \u03b2-lapachone: mechanisms, structural modifications, and therapeutic potentials","volume":"210","author":"Gong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116439_bib4","first-page":"131","article-title":"The chemotherapeutic effects of lapacho tree extract: \u03b2-lapachone","volume":"3","author":"Kung","year":"2014","journal-title":"Chemotherapy"},{"key":"10.1016\/j.biopha.2024.116439_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101950","article-title":"The diverse functionality of NQO1 and its roles in redox control","volume":"41","author":"Ross","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2024.116439_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-00998-y","article-title":"A self-amplified nanocatalytic system for achieving \u201c1+ 1+ 1> 3\u201d chemodynamic therapy on triple negative breast cancer","volume":"19","author":"Zhou","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2024.116439_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/ars.2013.5462","article-title":"Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers","volume":"21","author":"Cao","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.biopha.2024.116439_bib8","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2007.25.18_suppl.15017","article-title":"A phase 2 study of ARQ 501 in combination with gemcitabine in adult patients with treatment na\u00efve, unresectable pancreatic adenocarcinoma","volume":"25","author":"Khong","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.116439_bib9","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2007.25.18_suppl.16509","article-title":"A phase II study of ARQ 501 in patients with advanced squamous cell carcinoma of the head and neck","volume":"25","author":"Kawecki","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.116439_bib10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41416-018-0278-4","article-title":"Phase 1 study of ARQ 761, a \u03b2-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis","volume":"119","author":"Gerber","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.116439_bib11","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.2147\/DDDT.S151269","article-title":"Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD (P) H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials","author":"Kim","year":"2017","journal-title":"Drug Des.\u00a0Dev. Ther."},{"key":"10.1016\/j.biopha.2024.116439_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.03.005","article-title":"Hydroxytyrosol protects from aging process via AMPK and autophagy; a review of its effects on cancer, metabolic syndrome, osteoporosis, immune-mediated and neurodegenerative diseases","author":"de Pablos","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2024.116439_bib13","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1753-4887.2010.00278.x","article-title":"Hydroxytyrosol: from laboratory investigations to future clinical trials","volume":"68","author":"Granados-Principal","year":"2010","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.biopha.2024.116439_bib14","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1007\/s00394-018-1864-1","article-title":"Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt\/\u03b2-catenin and TGF\u03b2 signaling pathways","volume":"58","author":"Cruz-Lozano","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.biopha.2024.116439_bib15","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2174\/1871520619666190722101207","article-title":"Hydroxytyrosol and oleuropein inhibit migration and invasion of MDA-MB-231 triple-negative breast cancer cell via induction of autophagy","volume":"19","author":"Lu","year":"2019","journal-title":"Anti-Cancer Agents Med. Chem."},{"key":"10.1016\/j.biopha.2024.116439_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203892","article-title":"Hypoxia modulates the antioxidant effect of hydroxytyrosol in MCF-7 breast cancer cells","volume":"13","author":"Calahorra","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116439_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-63417-6","article-title":"Crosstalk between hydroxytyrosol, a major olive oil phenol, and HIF-1 in MCF-7 breast cancer cells","volume":"10","author":"Calahorra","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116439_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.neuint.2016.03.005","article-title":"Hydroxytyrosol induces phase II detoxifying enzyme expression and effectively protects dopaminergic cells against dopamine-and 6-hydroxydopamine induced cytotoxicity","volume":"96","author":"Yu","year":"2016","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.biopha.2024.116439_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109256","article-title":"Hydroxytyrosol attenuates diquat-induced oxidative stress by activating Nrf2 pathway and modulating colonic microbiota in mice","volume":"113","author":"Han","year":"2023","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2024.116439_bib20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/13880209.2015.1042980","article-title":"Olive oil and its phenolic compounds (hydroxytyrosol and tyrosol) ameliorated TCDD-induced heptotoxicity in rats via inhibition of oxidative stress and apoptosis","volume":"54","author":"Kalaiselvan","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.biopha.2024.116439_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.canlet.2018.04.042","article-title":"Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile","volume":"429","author":"Jim\u00e9nez","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2024.116439_bib22","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41416-018-0287-3","article-title":"Dasatinib sensitises triple negative breast cancer cells to chemotherapy by targeting breast cancer stem cells","volume":"119","author":"Tian","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.116439_bib23","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1093\/bioinformatics\/btz436","article-title":"snakePipes: facilitating flexible, scalable and integrative epigenomic analysis","volume":"35","author":"Bhardwaj","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2024.116439_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2024.116439_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.biopha.2024.116439_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.biopha.2024.116439_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.biopha.2024.116439_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2024.116439_bib29","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1158\/1078-0432.CCR-17-3125","article-title":"Activating transcription factor 4 modulates TGF\u03b2-induced aggressiveness in triple-negative breast cancer via SMAD2\/3\/4 and mTORC2 signaling","volume":"24","author":"Gonz\u00e1lez-Gonz\u00e1lez","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2024.116439_bib30","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.3390\/molecules28093886","article-title":"Metabolomics insights into the differential response of breast cancer cells to the phenolic compounds hydroxytyrosol and luteolin","volume":"28","author":"Garcia-Guasch","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116439_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-022-01341-0","article-title":"Recent advances in therapeutic strategies for triple-negative breast cancer","volume":"15","author":"Li","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2024.116439_bib32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/antiox10020205","article-title":"Antioxidants for the treatment of breast cancer: are we there yet?","volume":"10","author":"Gri\u00f1an-Lison","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.biopha.2024.116439_bib33","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3390\/molecules28031022","article-title":"Exploration of the use of natural compounds in combination with chemotherapy drugs for tumor treatment","volume":"28","author":"Wu","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116439_bib34","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00394-018-1638-9","article-title":"Modulation by hydroxytyrosol of oxidative stress and antitumor activities of paclitaxel in breast cancer","volume":"58","author":"El-Azem","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.biopha.2024.116439_bib35","article-title":"Tailored beta-lapachone nanomedicines for cancer-specific therapy","author":"Li","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biopha.2024.116439_bib36","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.7150\/ijms.45706","article-title":"NAD (P) H: quinone oxidoreductase 1 determines radiosensitivity of triple negative breast cancer cells and is controlled by long non-coding RNA NEAT1","volume":"17","author":"Lin","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.biopha.2024.116439_bib37","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1016\/j.bmc.2007.07.043","article-title":"Synthesis and potent antitumor activity of new arylamino derivatives of nor-\u03b2-lapachone and nor-\u03b1-lapachone","volume":"15","author":"da Silva J\u00fanior","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116439_bib38","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3892\/ijo.2015.2972","article-title":"Downregulation of Sp1 is involved in \u03b2-lapachone-induced cell cycle arrest and apoptosis in oral squamous cell carcinoma","volume":"46","author":"Jeon","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2024.116439_bib39","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/01635581.2017.1339818","article-title":"Hydroxytyrosol induces apoptosis and cell cycle arrest and suppresses multiple oncogenic signaling pathways in prostate cancer cells","volume":"69","author":"Zubair","year":"2017","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.biopha.2024.116439_bib40","article-title":"Anti-proliferative effects of hydroxytyrosol against breast cancer cell lines through induction of apoptosis","volume":"10","author":"Aghaei","year":"2023","journal-title":"Gene\u00a0Cell Tissue"},{"key":"10.1016\/j.biopha.2024.116439_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.freeradbiomed.2018.07.022","article-title":"\u03b2-Lapachone and its iodine derivatives cause cell cycle arrest at G2\/M phase and reactive oxygen species-mediated apoptosis in human oral squamous cell carcinoma cells","volume":"126","author":"Dias","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2024.116439_bib42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/cancers11070965","article-title":"Targeting cancer stem cells in triple-negative breast cancer","volume":"11","author":"Park","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2024.116439_bib43","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.3390\/ijms19123813","article-title":"NQO1 is required for \u03b2-lapachone-mediated downregulation of breast-cancer stem-cell activity","volume":"19","author":"Kim","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116439_bib44","first-page":"1","article-title":"\u03b2-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2024.116439_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.689839","article-title":"A systematic review to clarify the prognostic values of CD44 and CD44+ CD24-phenotype in triple-negative breast cancer patients: lessons learned and the road ahead","volume":"11","author":"Abdoli Shadbad","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2024.116439_bib46","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.33249","article-title":"Novel insights into the function of CD24: a driving force in cancer","volume":"148","author":"Altevogt","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.biopha.2024.116439_bib47","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1172\/JCI65416","article-title":"TGF-\u03b2 inhibition enhances chemotherapy action against triple-negative breast cancer","volume":"123","author":"Bhola","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2024.116439_bib48","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.3390\/biomedicines9101353","article-title":"Targeting drug chemo-resistance in cancer using natural products","volume":"9","author":"Talib","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2024.116439_bib49","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/iub.1756","article-title":"The glutathione cycle: glutathione metabolism beyond the \u03b3-glutamyl cycle","volume":"70","author":"Bachhawat","year":"2018","journal-title":"IUBMB\u00a0Life"},{"key":"10.1016\/j.biopha.2024.116439_bib50","article-title":"Involvement of endoplasmic reticulum stress and activation of MAP kinases in B-lapachone-induced human prostate cancer cell apoptosis","author":"Lien","year":"2008","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.biopha.2024.116439_bib51","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/1534735416681638","article-title":"\u03b2-Lapachone inhibits lung metastasis of colorectal cancer by inducing apoptosis of CT26 cells","volume":"16","author":"Kee","year":"2017","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.biopha.2024.116439_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025976","article-title":"\u03b2-lapachone significantly increases the effect of ionizing radiation to cause mitochondrial apoptosis via JNK activation in cancer cells","volume":"6","author":"Park","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2024.116439_bib53","doi-asserted-by":"crossref","unstructured":"C. Hetz Flores, K. Zhang, R.J. Kaufman, Mechanisms, Regulation and Functions of the Unfolded Protein Response,\u00a02020, 10.1038\/s41580-020-0250-z.","DOI":"10.1038\/s41580-020-0250-z"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224003238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:15:36Z","timestamp":1782342936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224003238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":53,"alternative-id":["S0753332224003238"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116439","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking the effective alliance of \u03b2-lapachone and hydroxytyrosol against triple-negative breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116439"}}